A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
Arsenic Trioxide is an old drug that has recently re- introduced into new medicine. It is very potent against a specific type of leukemic cells harboring translocation between chromosomes 15 and 17. It has been demonstrated that this drug is effective against all stages of acute promyelocytic leukem...
Main Author: | Alimoghaddam, Kamran |
---|---|
Format: | Online |
Language: | English |
Published: |
Tehran University of Medical Sciences
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305381/ |
Similar Items
-
Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
by: Mathews, Vikram, et al.
Published: (2011) -
Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line
by: Baek, Jin Ho, et al.
Published: (2012) -
Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
by: Au, Wing-Yan, et al.
Published: (2012) -
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
by: Chen, Baowei, et al.
Published: (2013) -
Severe Acute Axonal Neuropathy following Treatment with Arsenic Trioxide for Acute Promyelocytic Leukemia: a Case Report
by: Kühn, Marcus, et al.
Published: (2016)